Cargando…

Prevalence of cerebral venous thrombosis with the use of oral contraceptive pills during the Holy month of Ramadan

OBJECTIVES: To identify the epidemiologic profile of cerebral vein thrombosis (CVT) among fasting women using oral contraceptive pills (OCPs) during the holy month of Ramadan. METHODS: This retrospective study was conducted on all patients diagnosed with CVT and using OCPs from records at a tertiary...

Descripción completa

Detalles Bibliográficos
Autores principales: AlSheef, Mohammed, Alotaibi, Mastourah, Zaidi, Abdul Rehman Z., Alshamrani, Areej, Alhamidi, Aroub, Zaidi, Syed Ziauddin A., Alanazi, Noor, Alhathlool, Sarah, Alarfaj, Ohoud, AlHazzaa, Mohammed, Kullab, Ghaydaa, Alboghdadly, Amany, Abu-Shaheen, Amani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Medical Journal 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841506/
https://www.ncbi.nlm.nih.gov/pubmed/33026046
http://dx.doi.org/10.15537/smj.2020.10.25397
Descripción
Sumario:OBJECTIVES: To identify the epidemiologic profile of cerebral vein thrombosis (CVT) among fasting women using oral contraceptive pills (OCPs) during the holy month of Ramadan. METHODS: This retrospective study was conducted on all patients diagnosed with CVT and using OCPs from records at a tertiary care hospital in Riyadh, Saudi Arabia during 2016-2017. The study participants were categorized into 2 groups (an intermittently fasting group during the holy month of Ramadan and a non-fasting group). RESULTS: Out of 108 female patients with CVT, 36.1% were secondary to OCP, of whom 41% participants were fasting. The most affected site was the transverse sinus. Holocephalic headache was more common amongst fasting group (68.8%) compared to non-fasting group (30.4%) (p=0.025). Dehydration (p=0.003) amongst the fasting group and protein S deficiency (p=0.027) in the non-fasting group were identified as the 2 prominent risk factors. Unfractionated heparin was the most common anticoagulant therapies used during the initiation phase for non-fasting (36.4%) and fasting groups (50%). CONCLUSION: All women who are using OCP should undergo formal written risk assessments for factors of CVT. Our study suggests that the negative effects of OCPs use might outweigh its benefits; thus, it should be prescribed with caution, more so in fasting patients.